NDC 61958-0403

Viread

Tenofovir Disoproxil Fumarate

Viread is a Oral Powder in the Human Prescription Drug category. It is labeled and distributed by Gilead Sciences, Inc.. The primary component is Tenofovir Disoproxil Fumarate.

Product ID61958-0403_741e31d6-533d-4da5-8a00-364d657ee3ab
NDC61958-0403
Product TypeHuman Prescription Drug
Proprietary NameViread
Generic NameTenofovir Disoproxil Fumarate
Dosage FormPowder
Route of AdministrationORAL
Marketing Start Date2012-01-18
Marketing CategoryNDA / NDA
Application NumberNDA022577
Labeler NameGilead Sciences, Inc.
Substance NameTENOFOVIR DISOPROXIL FUMARATE
Active Ingredient Strength40 mg/g
Pharm ClassesHuman Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Nucleosides [CS],Nucleoside Reverse Transcriptase Inhibitors [MoA]
NDC Exclude FlagN
Listing Certified Through2022-12-31

Packaging

NDC 61958-0403-1

1 BOTTLE, PLASTIC in 1 CARTON (61958-0403-1) > 60 g in 1 BOTTLE, PLASTIC
Marketing Start Date2012-01-18
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 61958-0403-1 [61958040301]

Viread POWDER
Marketing CategoryNDA
Application NumberNDA022577
Product TypeHUMAN PRESCRIPTION DRUG
Billing UnitGM
Marketing Start Date2012-01-18

Drug Details

Active Ingredients

IngredientStrength
TENOFOVIR DISOPROXIL FUMARATE40 mg/g

OpenFDA Data

SPL SET ID:33fd6418-fbdc-42ca-a50d-ce2a476a5418
Manufacturer
UNII
RxNorm Concept Unique ID - RxCUI
  • 1243324
  • 1243346
  • 1243343
  • 349251
  • 1243326
  • 1243227
  • 1243330
  • 1243229
  • 1243328
  • 352050

    • Pharmacological Class

    • Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]
    • Nucleoside Analog [EXT]
    • Nucleoside Reverse Transcriptase Inhibitors [MoA]
    • Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]

    NDC Crossover Matching brand name "Viread" or generic name "Tenofovir Disoproxil Fumarate"

    NDCBrand NameGeneric Name
    50090-0754VireadTENOFOVIR DISOPROXIL FUMARATE
    53808-0810Vireadtenofovir disoproxil fumarate
    61958-0401VireadTENOFOVIR DISOPROXIL FUMARATE
    61958-0403VireadTENOFOVIR DISOPROXIL FUMARATE
    61958-0404VireadTENOFOVIR DISOPROXIL FUMARATE
    61958-0405VireadTENOFOVIR DISOPROXIL FUMARATE
    61958-0406VireadTENOFOVIR DISOPROXIL FUMARATE
    69189-0401VireadViread
    70518-0546VireadViread
    0093-7104Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    16714-820Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    31722-535Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    42291-800Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    42385-901Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    50268-758TENOFOVIR DISOPROXIL FUMARATEtenofovir disoproxil fumarate
    53808-1128TENOFOVIR DISOPROXIL FUMARATEtenofovir disoproxil fumarate
    60505-4666Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    60687-366Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    64380-714TENOFOVIR DISOPROXIL FUMARATEtenofovir disoproxil fumarate
    65862-421Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate
    65862-818Tenofovir Disoproxil FumarateTenofovir Disoproxil Fumarate

    Trademark Results [Viread]

    Mark Image

    Registration | Serial
    Company
    Trademark
    Application Date
    VIREAD
    VIREAD
    76079330 2586295 Live/Registered
    Gilead Sciences, Inc.
    2000-06-28
    © 2024 FDA.report
    This site is not affiliated with or endorsed by the FDA.